Robbins LLP Urges AARD Stockholders to Contact Firm Regarding Potential Class Action
Law firm Robbins LLP is prompting Aardvark Therapeutics, Inc. stockholders who incurred losses to contact them concerning a filed class action lawsuit. The firm is seeking information from affected investors.
Shareholder rights law firm Robbins LLP is reminding investors who purchased Aardvark Therapeutics, Inc. (NASDAQ: AARD) stock and incurred losses that a class action lawsuit has been filed. The firm is seeking to represent these investors.
The lawsuit was filed on behalf of individuals and entities who purchased or acquired Aardvark Therapeutics common stock pursuant to the Company's... [further details needed from original press release to continue content].
Robbins LLP is urging investors who experienced financial losses in connection with their Aardvark Therapeutics stock purchases to contact the firm. This is to gather information regarding potential legal representation and the recovery of lost funds.